Aim of the study is to compare in hypertensive patients the effect of one year therapy with ACE-inhibitor (RAMIPRIL) or angiotensin II receptor blocker (IRBESARTAN) on left atrial remodelling and diastolic function.
|Condition||Renin-angiotensin system, Antihypertensives|
|Clinical Study Identifier||NCT00517322|
|Sponsor||Università degli Studi dell'Insubria|
|Last Modified on||7 November 2020|
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
No annotations made yet
Congrats! You have your own personal workspace now.